TY - JOUR
T1 - Association of serum interleukin-6 with mental health problems in children exposed to perinatal complications and social disadvantage
AU - Mansur, Rodrigo B.
AU - Cunha, Graccielle R.
AU - Asevedo, Elson
AU - Zugman, André
AU - Rizzo, Lucas B.
AU - Grassi-Oliveira, Rodrigo
AU - Levandowski, Mateus L.
AU - Gadelha, Ary
AU - Pan, Pedro M.
AU - Teixeira, Antônio L.
AU - McIntyre, Roger S.
AU - Mari, Jair J.
AU - Rohde, Luís A.
AU - Miguel, Eurípedes C.
AU - Bressan, Rodrigo A.
AU - Brietzke, Elisa
N1 - Publisher Copyright:
© 2016 Elsevier Ltd.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - There is consistent evidence that inflammation is involved in mental disorders pathogenesis. Herein, using data from the High Risk Cohort Study for Psychiatric Disorders, we investigated the relationship between parental mood disorders (PMD), environmental factors, serum interleukin-6 (IL6) and mental health problems in children aged 6-12. We measured the serum levels of IL6 in 567 children. Information related to socio-demographic characteristics, mental health problems and multiple risk factors, as well as parent's psychiatric diagnosis, was captured. We evaluated two groups of environmental risk factors (i.e. perinatal complications and social disadvantage) using a cumulative risk model. Results showed that higher serum levels of IL6 were associated with PMD (RR = 1.072, p = 0.001), perinatal complications (RR = 1.022, p = 0.013) and social disadvantage (RR = 1.024, p = 0.021). There was an interaction between PMD and social disadvantage (RR = 1.141, p = 0.021), as the effect of PMD on IL6 was significantly higher in children exposed to higher levels of social disadvantage. Moreover, there was a positive correlation between IL6 and mental health problems (RR = 1.099, p = 0.026), which was moderated by exposure to perinatal complications or social disadvantage (RR = 1.273, p = 0.015 and RR = 1.179, p = 0.048, respectively). In conclusions, there is evidence of a differential inflammatory activation in children with PMD and exposure to environmental risk factors, when compared to matched peers. Systemic inflammation may be involved in the pathway linking familial risk and mental health problems.
AB - There is consistent evidence that inflammation is involved in mental disorders pathogenesis. Herein, using data from the High Risk Cohort Study for Psychiatric Disorders, we investigated the relationship between parental mood disorders (PMD), environmental factors, serum interleukin-6 (IL6) and mental health problems in children aged 6-12. We measured the serum levels of IL6 in 567 children. Information related to socio-demographic characteristics, mental health problems and multiple risk factors, as well as parent's psychiatric diagnosis, was captured. We evaluated two groups of environmental risk factors (i.e. perinatal complications and social disadvantage) using a cumulative risk model. Results showed that higher serum levels of IL6 were associated with PMD (RR = 1.072, p = 0.001), perinatal complications (RR = 1.022, p = 0.013) and social disadvantage (RR = 1.024, p = 0.021). There was an interaction between PMD and social disadvantage (RR = 1.141, p = 0.021), as the effect of PMD on IL6 was significantly higher in children exposed to higher levels of social disadvantage. Moreover, there was a positive correlation between IL6 and mental health problems (RR = 1.099, p = 0.026), which was moderated by exposure to perinatal complications or social disadvantage (RR = 1.273, p = 0.015 and RR = 1.179, p = 0.048, respectively). In conclusions, there is evidence of a differential inflammatory activation in children with PMD and exposure to environmental risk factors, when compared to matched peers. Systemic inflammation may be involved in the pathway linking familial risk and mental health problems.
KW - Children
KW - Familial mood disorder
KW - Inflammation
KW - Mental health problems
KW - Perinatal complications
KW - Social disadvantage
UR - https://www.scopus.com/pages/publications/84971468246
UR - https://www.scopus.com/pages/publications/84971468246#tab=citedBy
U2 - 10.1016/j.psyneuen.2016.05.015
DO - 10.1016/j.psyneuen.2016.05.015
M3 - Article
C2 - 27258821
AN - SCOPUS:84971468246
SN - 0306-4530
VL - 71
SP - 94
EP - 101
JO - Psychoneuroendocrinology
JF - Psychoneuroendocrinology
ER -